“One Health” Perspective on Prevalence of ESKAPE Pathogens in Africa: A Systematic Review and Meta-Analysis
-
Published:2024-09-12
Issue:9
Volume:13
Page:787
-
ISSN:2076-0817
-
Container-title:Pathogens
-
language:en
-
Short-container-title:Pathogens
Author:
Khasapane Ntelekwane George1ORCID, Nkhebenyane Sebolelo Jane1, Lekota Kgaugelo2, Thekisoe Oriel2, Ramatla Tsepo12
Affiliation:
1. Centre for Applied Food Safety and Biotechnology, Department of Life Sciences, Central University of Technology, 1 Park Road, Bloemfontein 9300, South Africa 2. Unit for Environmental Sciences and Management, North-West University, Potchefstroom 2531, South Africa
Abstract
The leading cause of hospital-acquired infections worldwide includes Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp. (ESKAPE) infections. These bacteria are commonly isolated from clinical settings and linked to a number of potentially fatal diseases associated with hospitals. The objective of this study was to review the prevalence of ESKAPE pathogens in Africa. We gathered and systematically reviewed the literature concerning the prevalence of ESKAPE pathogens, published in the English language from January 2014 to February 2024, from three databases (PubMed, Web of Science and ScienceDirect). Our overall results revealed that S. aureus was the most prevalent species (79.5%), followed by A. baumannii (27.6%), K. pneumoniae (24.2%), Enterobacter spp. (20%), P. aeruginosa (9.0%), and E. faecium (5.1%). Moreover, stool samples had the highest Pooled Prevalence Estimates (PPEs) of 44.0%, followed by urine, nasal, and blood samples with 37.3%, 26.9%, and 22.9%, respectively. For the diagnostic method used to identify these ESKAPE pathogens, VITEK-MS had the highest PPE of 55.2%, followed by whole genome sequencing and PCR with 37.1% and 33.2%, respectively. The highest PPE of ESKAPE pathogens was recorded in West Africa with 77.3%, followed by Central/Middle Africa and East Africa with 43.5% and 25.1%, respectively. The overall PPE of ESKAPE pathogens from humans, animals, the environment (water, soil, and surfaces) and food sources was 35.8%, 37.3%, 47.7%, and 34.2%, respectively. Despite their prevalence in nosocomial settings, studies have shown that the ESKAPE pathogens may be isolated from a range of environmental reservoirs, including soil, dumping sites, beach sand, wastewater, food, and fish farms, among others. This wide source of ESKAPE pathogens substrates indicates the need for a multidisciplinary collaborative partnership for epidemiological studies and intervention efforts by the human, veterinary, and environmental health sectors in Africa.
Funder
Central University of Technology, South Africa, for their UCDP M and D funding
Reference47 articles.
1. Loyola-Cruz, M.Á., Gonzalez-Avila, L.U., Martínez-Trejo, A., Saldaña-Padilla, A., Hernández-Cortez, C., Bello-López, J.M., and Castro-Escarpulli, G. (2023). ESKAPE and beyond: The burden of coinfections in the COVID-19 pandemic. Pathogens, 12. 2. Catalano, A., Iacopetta, D., Ceramella, J., Pellegrino, M., Giuzio, F., Marra, M., Rosano, C., Saturnino, C., Sinicropi, M.S., and Aquaro, S. (2023). Antibiotic-resistant ESKAPE pathogens and COVID-19: The pandemic beyond the pandemic. Viruses, 15. 3. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: No ESKAPE;Rice;J. Infect. Dis.,2008 4. Santajit, S., and Indrawattana, N. (2016). Mechanisms of antimicrobial resistance in ESKAPE pathogens. BioMed Res. Int., 2016. 5. Mulani, M.S., Kamble, E.E., Kumkar, S.N., Tawre, M.S., and Pardesi, K.R. (2019). Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: A review. Front. Microbiol., 10.
|
|